Immune response profiling identifies autoantibodies specific to Moyamoya patients

Orphanet Journal of Rare Diseases

Volumn 8, Issue 1, 2013, Pages

  Sigdel, Tara K ^a,b   Shoemaker, Lorelei D ^b,c,d   Chen, Rong ^b   Li, Li ^b   Butte, Atul J ^b   Sarwal, Minnie M ^a,b   Steinberg, Gary K ^b,c,d  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY   (United States)

^d Stanford California and Cofounder   (United States)

Author keywords

Autoantibodies; Cerebrovascular disease; Moyamoya; Protein microarray

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMYLOID BETA A4 PROTEIN ANTIBODY; ASPARTOACYLASE; AUTOANTIBODY; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CASEIN KINASE IDELTA; CATENIN BETA1 ANTIBODY; CD7 ANTIGEN; CD79A ANTIGEN; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ENDOGLIN; EPHRIN A3; G PROTEIN PATHWAY SUPPRESSOR 1 ANTIBODY; G PROTEIN PATHWAY SUPRESSOR 1; GLUCOSE TRANSPORTER 2; HISTONE DEACETYLASE 1; IMMUNOGLOBULIN G ANTIBODY; INTERFERON ALPHA INDUCIBLE PROTEIN 6; MELANOCORTIN 2 RECEPTOR ACCESSORY PROTEIN; MYELOBLASTIN; MYOSIN LIGHT CHAIN KINASE ISOENZYME; PROTEIN P21; RAPTOR PROTEIN; RECEPTOR TRANSPORTER PROTEIN 2; RECEPTOR TYROSINE KINASE LIKE ORPHAN RECEPTOR 1 ANTIBODY; RNA POLYMERASE; SERINE THREONINE KINASE 25; STIMULATED BY RETINOIC ACID 13 ANTIBODY; THYROXINE DEIODINASE; TRANSMEMBRANE PROTEIN 32; UNCLASSIFIED DRUG;

ADULT; ARTERIOVENOUS MALFORMATION; ARTICLE; CAROTID ARTERY OBSTRUCTION; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DNA REPAIR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; MOYAMOYA DISEASE; PROTEIN EXPRESSION; PROTEIN MICROARRAY; PROTEIN PROCESSING; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; AUTOANTIBODIES; CEREBRAL ANGIOGRAPHY; CEREBROVASCULAR DISORDERS; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MOYAMOYA DISEASE; PROTEIN ARRAY ANALYSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; YOUNG ADULT;

EID: 84875169635     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-8-45     Document Type: Article

References (59)

1. Pathophysiology and genetic factors in moyamoya disease. Achrol A, Guzman R, Lee M, Steinberg G, Neurosurg Focus 2009 26 4 19485717
2. Neurosurgical advances in the treatment of moyamoya disease. Pandey P, Steinberg GK, Stroke 2011 42 3304 3310 10.1161/STROKEAHA.110.598565 21980214
3. Cerebrovascular moyamoya disease: disease showing abnormal net-like vessels in base of brain. Suzuki J, Takaku A, Arch Neurol 1969 20 288 299 10.1001/archneur.1969.00480090076012 5775283
4. Moyamoya disease: a review of histopathology, biochemistry, and genetics. Weinberg DG, Arnaout OM, Rahme RJ, Aoun SG, Batjer HH, Bendok BR, Neurosurg Focus 2011 30 20 10.3171/2011.3.FOCUS1151 21631222
5. Polymorphisms in TGFB1 and PDGFRB are associated with moyamoya disease in European patients. Roder C, Peters V, Kasuya H, Nishizawa T, Takehara Y, Berg D, Schulte C, Khan N, Tatagiba M, Krischek B, Acta Neurochir 2010 152 2153 2160 10.1007/s00701-010-0711-9 20571834
6. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Miskinyte S, Butler Matthew G, Herve D, Sarret C, Nicolino M, Petralia Jacob D, Bergametti F, Arnould M, Van Pham N, Gore Aniket V, Am J Hum Genet 2011 88 718 728 10.1016/j.ajhg.2011.04.017 21596366
7. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, Kanno J, Niihori T, Ono M, Ishii N, J Hum Genet 2010 56 34 40 21048783
8. Levels of soluble adhesion molecules are elevated in the cerebrospinal fluid of children with moyamoya syndrome. Soriano S, Cowan D, Proctor M, Scott R, Neurosurgery 2002 50 544 549 11841722 (Pubitemid 36322837)
9. Majewski osteodysplastic primordial dwarfism type II (MOPD II): Expanding the vascular phenotype. Bober MB, Khan N, Kaplan J, Lewis K, Feinstein JA, Scott CI, Steinberg GK, Am J Med Genet A 2010 152A 960 10.1002/ajmg.a.33252 20358609
10. Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling. Griffith E, Walker S, Martin C-A, Vagnarelli P, Stiff T, Vernay B, Sanna NA, Saggar A, Hamel B, Earnshaw WC, Nat Genet 2008 40 232 10.1038/ng.2007.80 18157127 (Pubitemid 351171398)
11. Moyamoya disease and moyamoya syndrome. Scott RM, Smith ER, N Engl J Med 2009 360 1226 1237 10.1056/NEJMra0804622 19297575
12. Prothrombotic disorders in children with moyamoya syndrome. Bonduel M, Hepner M, Sciuccati G, Torres AF, Tenembaum S, de Veber G, Stroke 2001 32 1786 1792 10.1161/01.STR.32.8.1786 11486106
13. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study. Kim SJ, Heo KG, Shin HY, Bang OY, Kim G-M, Chung C-S, Kim KH, Jeon P, Kim JS, Hong S-C, Lee KH, Stroke 2010 41 173 176 10.1161/STROKEAHA.109.562264 19926842
14. Increased thyroid function and elevated thyroid autoantibodies in pediatric patients with moyamoya disease. Li H, Zhang Z-S, Dong Z-N, Ma M-J, Yang W-Z, Han C, Du M-M, Liu Y-X, Yang H, Liu W, Stroke 2011 42 1138 1139 10.1161/STROKEAHA.110.608471 21350209
15. Anti-alpha-Fodrin autoantibodies in moyamoya disease. Ogawa K, Nagahiro S, Arakaki R, Ishimaru N, Kobayashi M, Hayashi Y, Stroke 2003 34 244 e246 10.1161/01.STR.0000100479.63243.48 14657555
16. SEREX identification of the autoantibodies that are prevalent in the cerebrospinal fluid of patients with moyamoya disease. Kim J, Kim S-K, Wang K-C, Kim H-Y, Jeoung D, Biotechnol Lett 2004 26 585 15168859
17. Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease. Butte AJ, Sigdel TK, Wadia PP, Miklos DB, Sarwal MM, Mol Cell Proteomics 2011 3 10.1074/mcp.M110.000497-1 10.1074/mcp.M110.000497-8
18. Autoantigen microarrays for multiplex characterization of autoantibody responses. Robinson WH, DiGennaro C, Hueber W, Haab BB, Kamachi M, Dean EJ, Fournel S, Fong D, Genovese MC, de Vegvar HEN, Nat Med 2002 8 295 10.1038/nm0302-295 11875502 (Pubitemid 34250109)
19. Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury. Sigdel TK, Li L, Tran TQ, Khatri P, Naesens M, Sansanwal P, Dai H, Hsieh S-c, Sarwal MM, J Am Soc Nephrol 2012 23 750 763 10.1681/ASN.2011060596 22302197
20. Robust-linear-model normalization to reduce technical variability in functional protein microarrays. Sboner A, Karpikov A, Chen G, Smith M, Dawn M, Freeman-Cook L, Schweitzer B, Gerstein MB, J Proteome Res 2009 8 5451 5464 10.1021/pr900412k 19817483
21. FitSNPs: highly differentially expressed genes are more likely to have variants associated with disease. Chen R, Morgan A, Dudley J, Deshpande T, Li L, Kodama K, Chiang A, Butte A, Genome Biol 2008 9 170 10.1186/gb-2008-9-12-r170 19061490
22. McKusick VA, Mendelian inheritance in man: a catalog of human genes and genetic disorders Baltimore: Johns Hopkins University Press 1998
23. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Swaminathan PD, Purohit A, Hund TJ, Anderson ME, Circ Res 2012 110 1661 1677 10.1161/CIRCRESAHA.111.243956 22679140
24. Characterization of the role of CaMKI-like kinase (CKLiK) in human granulocyte function. Verploegen S, Ulfman L, van Deutekom HWM, van Aalst C, Honing H, Lammers J-WJ, Koenderman L, Coffer PJ, Blood 2005 106 1076 1083 10.1182/blood-2004-09-3755 15840691 (Pubitemid 41076457)
25. Initiation and processing of signals from the b cell antigen receptor. Reth M, Wienands J, Annu Rev Immunol 1997 15 453 479 10.1146/annurev.immunol.15. 1.453 9143696 (Pubitemid 27169289)
26. Developmental endothelial locus-1 (Del-1), a novel angiogenic protein. Ho H-KV, Jang JJ, Kaji S, Spektor G, Fong A, Yang P, Hu BS, Schatzman R, Quertermous T, Cooke JP, Circulation 2004 109 1314 1319 10.1161/01.CIR. 0000118465.36018.2D 14981004 (Pubitemid 38372792)
27. EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions. Sharfe N, Nikolic M, Cimpeon L, Van De Kratts A, Freywald A, Roifman CM, Mol Immunol 2008 45 1208 10.1016/j.molimm.2007.09.019 17980912 (Pubitemid 350299492)
28. CD7 Is a differentiation marker that identifies multiple CD8 T cell effector subsets. Aandahl EM, Sandberg JK, Beckerman KP, Taskén K, Moretto WJ, Nixon DF, J Immunol 2003 170 2349 2355 12594257 (Pubitemid 36245621)
29. G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells. Cheriyath V, Glaser KB, Waring JF, Baz R, Hussein MA, Borden EC, J Clin Invest 2007 117 3107 10.1172/JCI31122 17823654 (Pubitemid 47529640)
30. Isolation and characterization of human casein kinase I (CKI), a novel member of the CKI gene family. Fish KJ, Cegielska A, Getman ME, Landes GM, Virshup DM, J Biol Chem 1995 270 14875 14883 10.1074/jbc.270.25.14875 7797465
31. Dilated cardiomyopathy in thyrotoxicosis and Moyamoya disease. Kim JY, Kim BS, Kang JH, Int J Cardiol 2001 80 101 10.1016/S0167-5273(01)00475-2 11575263 (Pubitemid 32800816)
32. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes. Fiedler B, Lohmann SM, Smolenski A, Linnemuller S, Pieske B, Schroder F, Molkentin JD, Drexler H, Wollert KC, Proc Natl Acad Sci 2002 99 11363 11368 10.1073/pnas.162100799 12177418 (Pubitemid 34920931)
33. Defective smooth muscle regulation in cGMP kinase I-deficient mice. Pfeifer A, Klatt P, Massberg S, Ny L, Sausbier M, Hirneisz C, Wang G-X, Korth M, Aszodi A, Andersson K-E, EMBO J 1998 17 3045 10.1093/emboj/17.11.3045 9606187 (Pubitemid 28254377)
34. LIM-kinase1 hemizygosity implicated in impaired visuospatial constructive cognition. Frangiskakis JM, Ewart AK, Morris CA, Mervis CB, Bertrand J, Robinson BF, Klein BP, Ensing GJ, Everett LA, Green ED, Cell 1996 86 59 10.1016/S0092-8674(00)80077-X 8689688 (Pubitemid 26256578)
35. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Kaden JJ, Dempfle CE, Grobholz R, Fischer CS, Vocke DC, Kiliç R, Sarikoç A, Piñol R, Hagl S, Lang S, Cardiovasc Pathol 2005 14 80 10.1016/j.carpath.2005.01.002 15780799 (Pubitemid 40381303)
36. Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state. Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP, Circulation 2007 115 1398 1407 10.1161/CIRCULATIONAHA.106.643585 17353445 (Pubitemid 46648375)
37. Molecular cloning and characterization of the human ASB-8 gene encoding a novel member of ankyrin repeat and SOCS box containing protein family. Liu Y, Li J, Zhang F, Qin W, Yao G, He X, Xue P, Ge C, Wan D, Gu J, Biochem Biophys Res Commun 2003 300 972 10.1016/S0006-291X(02)02971-6 12559969 (Pubitemid 36259857)
38. SLC39A9 (ZIP9) regulates zinc homeostasis in the secretory pathway: characterization of the ZIP subfamily I protein in vertebrate cells. Matsuura W, Yamazaki T, Yamaguchi-Iwai Y, Masuda S, Nagao M, Andrews GK, Kambe T, Biosci Biotechnol Biochem 2009 73 1142 10.1271/bbb.80910 19420709
39. Towards a knowledge-based Human Protein Atlas. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, Nat Biotech 2010 28 1248 10.1038/nbt1210-1248
40. Essential roles for Fe65, alzheimer amyloid precursor-binding protein, in the cellular response to DNA damage. Minopoli G, Stante M, Napolitano F, Telese F, Aloia L, De Felice M, Di Lauro R, Pacelli R, Brunetti A, Zambrano N, Russo T, J Biol Chem 2007 282 831 835 17121854 (Pubitemid 47076515)
41. Fe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks. Stante M, Minopoli G, Passaro F, Raia M, Vecchio LD, Russo T, Proc Natl Acad Sci 2009 106 5093 5098 10.1073/pnas.0810869106 19282473
42. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. Winkler D, Bondolfi L, Herzig M, Jann L, Calhoun M, Wiederhold K, Tolnay M, Staufenbiel M, Jucker M, J Neurosci 2001 21 1619 1627 11222652 (Pubitemid 32182202)
43. Chromosomal instability by beta-catenin//TCF transcription in APC or beta-catenin mutant cells. Aoki K, Aoki M, Sugai M, Harada N, Miyoshi H, Tsukamoto T, Mizoshita T, Tatematsu M, Seno H, Chiba T, Oncogene 2006 26 3511 17160019
44. Role of Wnt canonical pathway in hematological malignancies. Ge X, Wang X, J Hematol Oncol 2010 3 33 10.1186/1756-8722-3-33 20843302
45. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Chenn A, Walsh CA, Science 2002 297 365 369 10.1126/science.1074192 12130776 (Pubitemid 34790759)
46. Cloning and characterization of developmental endothelial locus-1: an embryonic endothelial cell protein that binds the alphavbeta3 integrin receptor. Hidai C, Zupancic T, Penta K, Mikhail A, Kawana M, Quertermous E, Aoka Y, Fukagawa M, Matsui Y, Platika D, Genes Dev 1998 12 21 33 10.1101/gad.12.1.21 9420328 (Pubitemid 28083655)
47. Del1 mediates VSMC adhesion, migration, and proliferation through interaction with integrin alpha5beta3. Rezaee M, Penta K, Quertermous T, Am J Physiol Heart Circ Physiol 2002 282 1924 H1932 11959660
48. Cytoskeleton network and cellular migration modulated by nuclear-localized receptor tyrosine kinase ROR1. Tseng H-C, Kao H-W, Ho M-R, Chen Y-R, Lin T-W, Lyu P-C, Lin W-C, Anticancer Res 2011 31 4239 4249 22199287
49. COP9 signalosome function in the DDR. Hannss R, Dubiel W, FEBS Lett 2011 585 2845 2852 10.1016/j.febslet.2011.04.027 21510940
50. A histone-fold complex and FANCM form a conserved DNA-remodeling complex to maintain genome stability. Yan Z, Delannoy M, Ling C, Daee D, Osman F, Muniandy PA, Shen X, Oostra AB, Du H, Steltenpool J, Mol Cell 2010 37 865 878 10.1016/j.molcel.2010.01.039 20347428
51. MHF1-MHF2, a histone-fold-containing protein complex, participates in the fanconi anemia pathway via FANCM. Singh TR, Saro D, Ali AM, Zheng X-F, C-h D, Killen MW, Sachpatzidis A, Wahengbam K, Pierce AJ, Xiong Y, Mol Cell 2010 37 879 886 10.1016/j.molcel.2010.01.036 20347429
52. The ABCs of CENPs. Perpelescu M, Fukagawa T, Chromosoma 2011 120 425 10.1007/s00412-011-0330-0 21751032
53. Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Wang W, Nat Rev Genet 2007 8 735 17768402
54. The Lys63-specific deubiquitinating enzyme BRCC36 is regulated by two scaffold proteins localizing in different subcellular compartments. Feng L, Wang J, Chen J, J Biol Chem 2010 285 30982 30988 10.1074/jbc.M110.135392 20656690
55. Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hussain S, Wilson JB, Medhurst AL, Hejna J, Witt E, Ananth S, Davies A, Masson J-Y, Moses R, West SC, Hum Mol Genet 2004 13 1241 1248 10.1093/hmg/ddh135 15115758 (Pubitemid 38877877)
56. Mutations in the pericentrin (PCNT) gene cause primordial dwarfism. Rauch A, Thiel CT, Schindler D, Wick U, Crow YJ, Ekici AB, van Essen AJ, Goecke TO, Al-Gazali L, Chrzanowska KH, Science 2008 319 816 819 10.1126/science.1151174 18174396 (Pubitemid 351225872)
57. Pericentrin in cellular function and disease. Delaval B, Doxsey SJ, J Cell Biol 2010 188 181 190 10.1083/jcb.200908114 19951897
58. Moyamoya syndrome after radiation therapy: case reports. Kim TG, Kim DS, Chung SS, Choi JU, Pediatr Neurosurg 2011 47 138 142 10.1159/000330541 21893954
59. Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. Fritzler MJ, Rattner JB, Luft LM, Edworthy SM, Casiano CA, Peebles C, Mahler M, Autoimmun Rev 2011 10 194 10.1016/j.autrev.2010.09.025 20933614